PhRMA Perspectives on Drug Substance Regulatory Filing Issues

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-02-02-2003
Volume 27
Issue 2

The PhRMA API Technical Group examines topics concerning active pharmaceutical ingredient development and manufacture and makes recommendations for regulatory guidance.

Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content